ATLANTA, Feb. 23 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it has sent the...
ATLANTA, Feb. 2 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it has purchased...
Company expects record revenues and operating profits in 2010 ATLANTA, Dec. 1 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular...
ATLANTA, Nov. 11 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that Steven G...
Company posts fully diluted earnings per share of $0.07 for third quarter of 2009; Revenues increased 5 percent for third quarter of 2009 compared to third quarter of 2008 ATLANTA, Oct. 29...
ATLANTA, Sept. 14 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it is scheduled...
Newly CE Marked Product Used to Stop Bleeding During Liver Resection ATLANTA and LONDON, Sept. 10 /PRNewswire-FirstCall/ -- CryoLife, Inc., (NYSE:CRY) an implantable biological medical device and...
ATLANTA, Aug. 18 /PRNewswire-FirstCall/ -- CryoLife, Inc., (NYSE:CRY) an implantable biological medical device and cardiovascular tissue processing company, today announced the first three...
Company posts fully diluted earnings per share of $0.09 for second quarter of 2009; Revenues increased 6 percent sequentially for second quarter of 2009 compared to first quarter of 2009 ATLANTA...
ATLANTA, Sept. 6 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE:CRY), a biomaterials and biosurgical device company, announced today that BioDisc(TM) Spinal Disc Repair System, a nucleus...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.33 | 0.33 | 0.33 | 0 | 0 | CS |
4 | 0 | 0 | 0.33 | 0.33 | 0.33 | 0 | 0 | CS |
12 | 0 | 0 | 0.33 | 0.33 | 0.33 | 0 | 0 | CS |
26 | 0 | 0 | 0.33 | 0.33 | 0.33 | 0 | 0 | CS |
52 | 0 | 0 | 0.33 | 0.33 | 0.33 | 0 | 0 | CS |
156 | 0 | 0 | 0.33 | 0.33 | 0.33 | 0 | 0 | CS |
260 | -0.31 | -48.4375 | 0.64 | 1.07 | 0.11 | 5867 | 0.3537305 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions